Dianthus Therapeutics Inc. (DNTH) Live Share Price, Invest From India

Dianthus Therapeutics Inc. Stock Performance

as on May 19, 2026 at 2:15 pm IST

Day's Low
Day's High
$81.34
Day's Price Range
$86.91
$83.60
2.70%
Downside
3.96%
Upside
52 Week's Low
52 Week's High
$16.64
52-Week Price Range
$96.50
$83.60
80.10%
Downside
15.43%
Upside

Dianthus Therapeutics Inc. share price movements today

Previous Close: $86.16
Open: $86.41
Volume: 598.0K
Day's Low - High: $81.34 - $86.91
52 Week Low - High: $16.64 - $96.50

Dianthus Therapeutics Inc. Historical Returns

1 Month Return: -7.61 %
3 Month Return: + 81.5 %
1 Year Return: + 337.58 %
3 Year Return: 0 %
5 Year Return: 0 %

Dianthus Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Dianthus Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.7B

EPS (TTM)

-3.8813

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-191.2M

Revenue (TTM)

1.3M

Profit Margin

0.00%

Return On Equity TTM

-22.70%

Dianthus Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Dianthus Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Dianthus Therapeutics Inc.	BUY	$4.7B	NA	NA	0.00%
Revolution Medicines Inc	BUY	$31.8B	341.26%	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$39.2B	112.34%	73.55	12.55%
Vertex Pharmaceuticals Inc	BUY	$115.0B	103.57%	26.89	35.51%
Regeneron Pharmaceuticals Inc	BUY	$74.7B	35.26%	17.39	29.65%

Stock Returns calculator for Dianthus Therapeutics Inc. Stock including INR - Dollar returns

The Dianthus Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Dianthus Therapeutics Inc. investment value today

Current value as on today

₹4,79,002

Returns

₹3,79,002

(+379%)

Returns from Dianthus Therapeutics Inc. Stock

₹3,24,581 (+324.58%)

Dollar Impact

₹54,421 (+54.42%)

Analyst Recommendation on Dianthus Therapeutics Inc. Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Dianthus Therapeutics Inc.. Average target price of $125.83

Dianthus Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Dianthus Therapeutics Inc..

What analysts predicted

33.56%UPSIDE

Target Price

$125.83

Current Price

$83.6

Analyzed by

12 Analysts

Target

$125.83

Dianthus Therapeutics Inc. target price $125.83, a slight upside of 33.56% compared to current price of $83.6. According to 12 analysts rating.

Indian Investors' Interest in Dianthus Therapeutics Inc. Stock

Search interest for Dianthus Therapeutics Inc. Stock has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Time period: April 19, 2026 to May 19, 2026

Change:-44% versus previous 30 day period

Dianthus Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	0	0	1	2	1	1	0	0	0	0
Gross Profit	0	0	1	2	1	1	0	0	0	0
Operating Income	-12	-17	-22	-29	-31	-33	-34	-40	-69	-46
EBITDA	-12	-17	-22	-29	-31	-33	-34	-36	-69	-46
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	-
Income Before Tax	-10	-13	-17	-25	-28	-29	-31	-36	97	-40
Income Tax Expense	0	0	-	-	-	-	-	-	-	-
Net Income	-10	-13	-17	-25	-28	-29	-31	-36	97	-40
Net Profit Margin	-2311.38%	-1573.00%	-945.09%	-1159.02%	-2144.80%	-2537.49%	-16388.08%	-9284.09%	34473.59%	-8819.44%

Dianthus Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	1	6	2	6	2
Gross Profit	1	6	2	6	2
Operating Income	-13	-29	-48	-101	-177
EBITDA	-13	-29	-47	-101	-177
Interest Expense	3	-	-	-	-
Depreciation	-	0	0	0	0
Income Before Tax	-13	-28	-43	-84	-162
Income Tax Expense	-1	-1	0	-	-
Net Income	-13	-28	-43	-84	-162
Net Profit Margin	-888.14%	-443.76%	-1541.22%	-1362.77%	-7973.33%

Dianthus Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-13	-17	-25	-28	-29	-31	-36	-64	-40
Operating Cash Flow	-14	-14	-21	-27	-27	-23	-30	-46	-28
Investing Cash Flow	-5	1	-259	-23	14	26	-201	37	-133
Financing Cash Flow	217	-2	0	39	0	0	274	4	739
Change in Cash	197	-15	-280	-10	-12	3	42	-4	576

Dianthus Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-35	-57	-76	-74	-71	-28	-43	-84	-162
Operating Cash Flow	-22	-41	-57	-64	-59	-29	-36	-78	-129
Investing Cash Flow	-2	-91	1	-10	43	-59	20	-286	-122
Financing Cash Flow	71	142	62	67	89	96	133	255	280
Change in Cash	47	6	6	-6	73	7	116	-109	28

Insights on Dianthus Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 3 Years
In the last 3 years, DNTH has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 3 months, DNTH stock has moved up by 73.3%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 284.0K → 463.0K (in $), with an average increase of 38.7% per quarter
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, DNTH has outperformed top 5 stocks with highest market-cap in its industry
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 97.90M → -40.83M (in $), with an average decrease of 141.7% per quarter

About Dianthus Therapeutics Inc.

Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein; and DNTH212, a bifunctional fusion protein that targets plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell function. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.

Organisation	Dianthus Therapeutics Inc.
Headquarters	7 Times Square, New York, NY, United States, 10036
Industry	Biotechnology
CEO	Mr. Marino Garcia M.B.A.
E-voting on shares	Click here to vote

Key Management of Dianthus Therapeutics Inc.

Name	Title
Mr. Ryan Savitz	Executive VP, CFO, Chief Business Officer & Treasurer
Dr. Simrat Randhawa M.B.A., M.D.	Executive VP and Head of R&D
Mr. Edward G. Carr	Senior VP & Chief Accounting Officer
Mr. Adam M. Veness Esq.	Senior VP, General Counsel & Secretary
Ms. Rashieda Gluck	Head of Clinical Development Operations
Mr. Marino Garcia M.B.A.	President, CEO & Director
Mr. Judson Taylor	Senior VP & Head of Technical Operations
Ms. Jennifer Davis Ruff	VP and Head of Investor Relations & Corporate Affairs
Ms. Kristina Maximenko	Chief People Officer
Mr. Scott Nogi M.B.A.	Head of Business Operations

FAQs

What is Dianthus Therapeutics Inc. share price today?

Dianthus Therapeutics Inc. share price today is $83.6 as on May 19, 2026 at 8:45 am IST at the close of the market. Dianthus Therapeutics Inc. share today touched a day high of $86.91 and a low of $81.34.

What is the 52 week high and 52 week low for Dianthus Therapeutics Inc. share?

Dianthus Therapeutics Inc. share touched a 52 week high of $96.5 on April 16, 2026 and a 52 week low of $16.64 on June 23, 2025. Dianthus Therapeutics Inc. stock price today i.e. May 19, 2026 at 8:45 am IST is closed at $83.6,which is 13.37% down from its 52 week high and 402.55% up from its 52 week low.

What is Dianthus Therapeutics Inc.'s market capitalisation today?

Dianthus Therapeutics Inc. market capitalisation is $0.00T as on May 19, 2026 at 8:45 am IST.

How to invest in Dianthus Therapeutics Inc. Stock (DNTH) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Dianthus Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dianthus Therapeutics Inc. Shares that will get you 0.0179 shares as per Dianthus Therapeutics Inc. share price of $83.6 per share as on May 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Dianthus Therapeutics Inc. Stock (DNTH) from India?

Indian investors can start investing in Dianthus Therapeutics Inc. (DNTH) shares with as little as ₹96.335 or $1 (as of May 19, 2026 at 2:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹963.35 in Dianthus Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on May 19, 2026 at 2:41 pm IST). Based on Dianthus Therapeutics Inc. share’s latest price of $83.6 as on May 19, 2026 at 8:45 am IST, you will get 0.1196 shares of Dianthus Therapeutics Inc.. Learn more about fractional shares .